Undisclosed Antiretroviral Drug Use in Botswana – Implication for National Estimates

Details

• Alternative Title:
  AIDS
• Personal Author:
  Moyo, Sikhulile ; Gaseitsiwe, Simani ; Powis, Kathleen M ; Holme, Molly Pretorius ; Mohammed, Terence ; Zahralban-Steele, Melissa ; Yankinde, Etienne Kadima ; Maphorisa, Comfort ; Abrams, William ; Lebelonyane, Refeletswe ; Manyake, Kutlo ; Sekoto, Tumalano ; Mmalane, Mompati ; Gaolathe, Tendani ; Wirth, Kathleen E. ; Makhema, Joseph ; Lockman, Shahin ; Clarke, William ; Essex, Max ; Novitsky, Vlad
• Description:
  : Among 3596 HIV-positive participants enrolled in the Botswana Combination Prevention Project who self-reported no prior antiretroviral (ARV) therapy use and were tested for viral load (n = 951; 27% of all participants), 136 (14%) had HIV-1 RNA less than 400 copies/ml. ARV drugs were detected in 52 (39%) of 134 participants tested. Adjusting for undisclosed ARV use increased the overall estimate of virally suppressed individuals on ARV therapy by 1.4% from 70.2 to 71.6%.
• Subjects:
  Antiretroviral Drugs (ARVs) Antiretroviral Therapy (ART) Article Botswana Estimate Of Virally Suppressed Undisclosed ART Use
• Source:
  AIDS. 32(11):1543-1546
• Pubmed ID:
  29762166
• Pubmed Central ID:
  PMC6047897
• Document Type:
  Journal Article
• Funding:
  U01 GH000447/GH/CGH CDC HHS/United States ; K24 AI131928/AI/NIAID NIH HHS/United States ; D43 TW010543/TW/FIC NIH HHS/United States ; U2G GH001911/GH/CGH CDC HHS/United States ; Wellcome Trust/United Kingdom ; PEPFAR/PEPFAR/United States ; 107752/Z/15/Z/Wellcome Trust/United Kingdom
• Volume:
  32
• Issue:
  11
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha256:8ddb22d8e0a4998e2357198ab98876d972cbb62207bcb05207675ae87cc9764c
• Download URL:
  https://stacks.cdc.gov/view/cdc/57175/cdc_57175_DS1.pdf
• File Type:
  [PDF - 49.55 KB ]